A total of 33 institutions have reported a stake in Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) as of December 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Beutel, Goodman & Co Ltd. | 31 Dec, 2025 | 3,709,373 | -349,526 | -8.61% | $27,926.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Dec, 2025 | 1,350,000 | 0 | 0.00% | $10,192,500.00 |
| Vivo Capital, LLC | 31 Dec, 2025 | 1,350,000 | 0 | 0.00% | $10,192,500.00 |
| SCOTIA CAPITAL INC. | 31 Dec, 2025 | 1,286,183 | 8,298 | 0.65% | $9,604,679.00 |
| GREAT POINT PARTNERS LLC | 31 Dec, 2025 | 1,200,000 | 0 | 0.00% | $9,060,000.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 712,104 | 712,104 | 0.00% | $5,376,437.00 |
| Squadron Capital Management LLC | 31 Dec, 2025 | 500,000 | 500,000 | 0.00% | $3,775,000.00 |
| Ally Bridge Group (NY) LLC | 31 Dec, 2025 | 397,895 | -517,105 | -56.51% | $3,004,107.00 |
| Velan Capital Investment Management LP | 31 Dec, 2025 | 352,000 | 0 | 0.00% | $2,657,600.00 |
| Affinity Asset Advisors, LLC | 31 Dec, 2025 | 300,000 | 0 | 0.00% | $2,265,000.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Dec, 2025 | 278,064 | 278,064 | 0.00% | $2,090,765.00 |
| BANK OF AMERICA CORP /DE/ | 31 Dec, 2025 | 253,321 | 207,744 | 455.81% | $1,912,574.00 |
| UBS Group AG | 31 Dec, 2025 | 220,024 | 124,268 | 129.78% | $1,661,181.00 |
| ROYAL BANK OF CANADA | 31 Dec, 2025 | 196,277 | -232,527 | -54.23% | $1,482,000.00 |
| SummitTX Capital, L.P. | 31 Dec, 2025 | 175,948 | 175,948 | 0.00% | $1,328,407.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 158,133 | 158,133 | 0.00% | $1,193,905.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Dec, 2025 | 156,331 | 156,331 | 0.00% | $1,180,299.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 155,766 | 134,366 | 627.88% | $1,168.00 |
| INGALLS & SNYDER LLC | 31 Dec, 2025 | 77,400 | 18,300 | 30.96% | $584.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 58,058 | 17,958 | 44.78% | $438,338.00 |